Global and United States Sleep Disorder Therapeutics Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Sleep Disorder Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Insomnia
- 1.2.3 Excessive Sleep
- 1.2.4 Disturbed Sleep
- 1.3 Market by Application
- 1.3.1 Global Sleep Disorder Therapeutics Market Share by Application: 2020 VS 2026
- 1.3.2 Hospital Pharmacies
- 1.3.3 Online Pharmacies
- 1.3.4 Retail Pharmacies
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Sleep Disorder Therapeutics Market Perspective (2015-2026)
- 2.2 Global Sleep Disorder Therapeutics Growth Trends by Regions
- 2.2.1 Sleep Disorder Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Sleep Disorder Therapeutics Historic Market Share by Regions (2015-2020)
- 2.2.3 Sleep Disorder Therapeutics Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Sleep Disorder Therapeutics Players by Market Size
- 3.1.1 Global Top Sleep Disorder Therapeutics Players by Revenue (2015-2020)
- 3.1.2 Global Sleep Disorder Therapeutics Revenue Market Share by Players (2015-2020)
- 3.2 Global Sleep Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Sleep Disorder Therapeutics Revenue
- 3.4 Global Sleep Disorder Therapeutics Market Concentration Ratio
- 3.4.1 Global Sleep Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Sleep Disorder Therapeutics Revenue in 2019
- 3.5 Key Players Sleep Disorder Therapeutics Area Served
- 3.6 Key Players Sleep Disorder Therapeutics Product Solution and Service
- 3.7 Date of Enter into Sleep Disorder Therapeutics Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Sleep Disorder Therapeutics Breakdown Data by Type (2015-2026)
- 4.1 Global Sleep Disorder Therapeutics Historic Market Size by Type (2015-2020)
- 4.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Type (2021-2026)
5 Sleep Disorder Therapeutics Breakdown Data by Application (2015-2026)
- 5.1 Global Sleep Disorder Therapeutics Historic Market Size by Application (2015-2020)
- 5.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Sleep Disorder Therapeutics Market Size (2015-2026)
- 6.2 North America Sleep Disorder Therapeutics Market Size by Type (2015-2020)
- 6.3 North America Sleep Disorder Therapeutics Market Size by Application (2015-2020)
- 6.4 North America Sleep Disorder Therapeutics Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Sleep Disorder Therapeutics Market Size (2015-2026)
- 7.2 Europe Sleep Disorder Therapeutics Market Size by Type (2015-2020)
- 7.3 Europe Sleep Disorder Therapeutics Market Size by Application (2015-2020)
- 7.4 Europe Sleep Disorder Therapeutics Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Sleep Disorder Therapeutics Market Size (2015-2026)
- 8.2 China Sleep Disorder Therapeutics Market Size by Type (2015-2020)
- 8.3 China Sleep Disorder Therapeutics Market Size by Application (2015-2020)
- 8.4 China Sleep Disorder Therapeutics Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Sleep Disorder Therapeutics Market Size (2015-2026)
- 9.2 Japan Sleep Disorder Therapeutics Market Size by Type (2015-2020)
- 9.3 Japan Sleep Disorder Therapeutics Market Size by Application (2015-2020)
- 9.4 Japan Sleep Disorder Therapeutics Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Sleep Disorder Therapeutics Market Size (2015-2026)
- 10.2 Southeast Asia Sleep Disorder Therapeutics Market Size by Type (2015-2020)
- 10.3 Southeast Asia Sleep Disorder Therapeutics Market Size by Application (2015-2020)
- 10.4 Southeast Asia Sleep Disorder Therapeutics Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
- 11.1 Sanofi
- 11.1.1 Sanofi Company Details
- 11.1.2 Sanofi Business Overview
- 11.1.3 Sanofi Sleep Disorder Therapeutics Introduction
- 11.1.4 Sanofi Revenue in Sleep Disorder Therapeutics Business (2015-2020))
- 11.1.5 Sanofi Recent Development
- 11.2 Sunovion Pharmaceuticals
- 11.2.1 Sunovion Pharmaceuticals Company Details
- 11.2.2 Sunovion Pharmaceuticals Business Overview
- 11.2.3 Sunovion Pharmaceuticals Sleep Disorder Therapeutics Introduction
- 11.2.4 Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
- 11.2.5 Sunovion Pharmaceuticals Recent Development
- 11.3 Takeda Pharmaceutical
- 11.3.1 Takeda Pharmaceutical Company Details
- 11.3.2 Takeda Pharmaceutical Business Overview
- 11.3.3 Takeda Pharmaceutical Sleep Disorder Therapeutics Introduction
- 11.3.4 Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2015-2020)
- 11.3.5 Takeda Pharmaceutical Recent Development
- 11.4 Somaxon Pharmaceuticals
- 11.4.1 Somaxon Pharmaceuticals Company Details
- 11.4.2 Somaxon Pharmaceuticals Business Overview
- 11.4.3 Somaxon Pharmaceuticals Sleep Disorder Therapeutics Introduction
- 11.4.4 Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
- 11.4.5 Somaxon Pharmaceuticals Recent Development
- 11.5 Vanda Pharmaceuticals
- 11.5.1 Vanda Pharmaceuticals Company Details
- 11.5.2 Vanda Pharmaceuticals Business Overview
- 11.5.3 Vanda Pharmaceuticals Sleep Disorder Therapeutics Introduction
- 11.5.4 Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
- 11.5.5 Vanda Pharmaceuticals Recent Development
- 11.6 Eli Lilly
- 11.6.1 Eli Lilly Company Details
- 11.6.2 Eli Lilly Business Overview
- 11.6.3 Eli Lilly Sleep Disorder Therapeutics Introduction
- 11.6.4 Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2015-2020)
- 11.6.5 Eli Lilly Recent Development
- 11.7 GSK
- 11.7.1 GSK Company Details
- 11.7.2 GSK Business Overview
- 11.7.3 GSK Sleep Disorder Therapeutics Introduction
- 11.7.4 GSK Revenue in Sleep Disorder Therapeutics Business (2015-2020)
- 11.7.5 GSK Recent Development
- 11.8 Neurim Pharmaceuticals
- 11.8.1 Neurim Pharmaceuticals Company Details
- 11.8.2 Neurim Pharmaceuticals Business Overview
- 11.8.3 Neurim Pharmaceuticals Sleep Disorder Therapeutics Introduction
- 11.8.4 Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
- 11.8.5 Neurim Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Global Sleep Disorder Therapeutics Scope and Market Size
Sleep Disorder Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sleep Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Insomnia
Excessive Sleep
Disturbed Sleep
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Based on regional and country-level analysis, the Sleep Disorder Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Sleep Disorder Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Sanofi
Sunovion Pharmaceuticals
Takeda Pharmaceutical
Somaxon Pharmaceuticals
Vanda Pharmaceuticals
Eli Lilly
GSK
Neurim Pharmaceuticals